BGLC.US BioNexus Gene Lab Corp Common stock

Basic Materials Chemicals USA Stocks
0.8210 USD
Close of Nov 14, 2026
0.8102 4.97
Market cap
USD 2.41M
P/E
-
P/B
0.34x
ROE
-21.3%
Dividend yield
0.92%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is BGLC.US undervalued?

Graham number

The Graham number of BioNexus Gene Lab Corp Common stock cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BioNexus Gene Lab Corp Common stock fundamental analysis

No fundamental analysis for BioNexus Gene Lab Corp Common stock yet.

BioNexus Gene Lab Corp Common stock stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, i…

Full company profile